Montreal—Management of neuromuscular block with rocuronium and its reversal with neostigmine and sugammadex according to a protocol is associated with a very low incidence of postoperative residual neuromuscular blockade, in a new study.
The researchers reported that neostigmine played an important role in the protocol, and resulted in significant cost savings compared with sugammadex alone for reversal.
“Instead of continuing research that’s been going on for decades examining